Integrating non-clinical and clinical evidence for prioritisation in paediatric oncology drug development: Regulatory experience with three PARP inhibitors
Integrating non-clinical and clinical evidence for prioritisation in paediatric oncology drug development: Regulatory experience with three PARP inhibitors. // EJC Paediatric Oncology. – URL: https://www.sciencedirect.com/science/article/pii/S2772610X26000711?dgcid=rss_sd_all
Integrating non-clinical and clinical evidence for prioritisation in paediatric oncology drug development: Regulatory experience with three PARP inhibitors. EJC Paediatric Oncology. https://www.sciencedirect.com/science/article/pii/S2772610X26000711?dgcid=rss_sd_all
“Integrating non-clinical and clinical evidence for prioritisation in paediatric oncology drug development: Regulatory experience with three PARP inhibitors.” EJC Paediatric Oncology.
@article{article43694,
title = {Integrating non-clinical and clinical evidence for prioritisation in paediatric oncology drug development: Regulatory experience with three PARP inhibitors},
journal = {EJC Paediatric Oncology},
url = {https://www.sciencedirect.com/science/article/pii/S2772610X26000711?dgcid=rss_sd_all}
}